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Summary Human hHbl beings to the type 11 hard keratin family and is physiologically expressed in hair shafts. In the present study, using
specific 3' and 5' probes for hHbl, we established that breast carcinomas ectopically express a hHbl 5'-truncated mRNA, and that this
transcript is restricted to malignant epithelial cells. Furthernore, an in vitro study indicated that it could be twanslated. We concluded that, in
breast carcinomas, expression of truncated hHbl is related to epithial cell transformation. Because the hHbl gene maps to 12q11-q13, a
chromosome region known to present several breakpoints in solid tumours, we propose that the hHbl gene might represent a target for such
alterations.
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By differential screening of a cDNA library established from
metastatic lymph nodes derived from a human breast cancer. we
have previously identified and cloned the MLN 137 cDNA
(Tomasetto et al. 1995) (accession no. X80197). This cDNA is 1124
nucleotides long and shows homologies with sheep wool keratin
K2-9 (Powell et al, 1992). At the same time, Rogers and co-workers
cloned the human hHbl cDNA counterpart of K2-9 (Rogers et al.
1995). The gene coding for hHbl has been mapped to the type H
keratin cluster at 12q1-q13 (Rogers et al, 1995). Comparison of
MLN137 andhHbl sequences showed that MLN137 corresponds to
the 3' halfofthe hHbl cDNA. In situ hybridization to human scalp
showed strong hHbl expression in the cortical cells ofthe hairshaft.
from the lowercortex. slightly above the apex ofthe dermal papilla.
to the upper third of the cortex (Regnier et al. 1997; Rogers et al.
1997). Furthermore, hHbl expression was also observed in the tran-
sitional cell layer in pilomatricoma, a tumour exhibiting follicular
differentiation (Regnier et al. 1997).
Keratins belong to a multigene family which contains more than
30 members. They are grouped into type I acidic and type H basic
to neutral proteins. The association of equimolar amounts of
distinct pairs of type I and type H keratins gives rise to interme-
diate filaments which are organized in networks in epithelial cells
(Bloemendal and Pieper. 1989). Most keratins correspond to soft
a-keratins, expressed in various types of epithelia, whereas hard
a-keratins are involved in the formation ofhair and nails. The hair
keratin family is composed of four major type I (Hal-4) and type
II (Hbl-4) keratins. and a minor pair (Hax and Hbx) (Heid et al,
1988). Recently. several other members have been reported for
type I and type H hair keratins. showing that these families are
more complex than previously assumed (Rogers et al. 1997).
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Little is known about the precise mechanisms underlying the
regulation of the hair-specific keratins. In addition to recognizing
motifs used by many eukaryotic genes in transcription. such as
API, AP2 and SPI sites. a number of potential regulatory motifs
have been identified. Two ofthem, referred to as the HK-1 (Rogers
and Powell, 1993) and LEF-1 (Zhou et al. 1995) motifs. have been
shown to be able to regulate tissue-specific expression ofkeratins.
Furthermore, because keratins form a gene cluster. their expres-
sion could, at least partially. be regulated by a locus activation
region.
In normal human breast tissue. immunohistochemical analysis
showed that the basal and luminal cells of the ducts can be
discriminated by the keratins they express. K5 and K14 are
specific to myoepithelial cells, whereas luminal cells are charac-
terized by expression of K7, K8. K18 and K19. Several soft
keratins are produced in breast carcinomas. and they are used as
tumour markers because their profile ofexpression correlates with
different types of epithelial differentiation and function (Trask
et al. 1990; Nathrath and Lane. 1994). They can be found intra-
tumourally and in the blood. circulating as partially degraded
complexes. High levels of K8. K18 and K19 in breast carcinomas
have been correlated with a better prognosis. whereas a decrease
of K5 was associated with tumour progression (Trask et al. 1990:
Nathrath and Lane. 1994).
Here. we have studied the expression of hHbl in benign and
malignant breast tumours by Northern blot analysis using 3' and 5'
probes specific for hHbl.
MATERIALS AND METHODS
Human cell lines and tissues
Breast cancer cell lines are described and are available im the
American Type Culture Collection (ATCC. Rockville. MD. USA).
Cells were routinely cultured in Dulbecco's modified Eagle
medium supplemented with 10% fetal calfserum.
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Table 1 Clinical and biochemical characteristics of breast tumours
expressing MLN1 37
Patient Age Meno Grade ER PR pS2 LN
1 26 - II - - - 0/10
2 49 - I -- 0/9
3 55 + I- 0/12
4 32 - ll - - - 3/18
5 53 + ll + + + 1/12
6 41 - ll + - - 2/7
7 70 + + + + 0/9
Meno. menopausal status of the patients: grade, Scarff. Bloom and
Richardson tumnour grade: ER and PR. oestrogen and progesterone
receptors, respectively: -. negative: +. positive: LN. axillary lymph nodes.
number of metastatic LN vs number of studied LN.
Surgical specimens w~ere obtained at the H6pitaux Unix ersitaires
de Strasbourg. Depending, on subsequent anals sis. theywv~ere either
immediately, frozen in liquid nitrogen IRNA extraction). or fixed in
phosphate-buffered formalin (4%) and embedded in paraffin (histo-
logical analx sis and in situ hN-bri'dization).
Construction of a hairy skin cDNA library and cloning
of the full-length hHbl cDNA
PoINyIAIRNA from normal hairx% skin A-as used to construct a
cDNA librarx xAith the Uni-ZAP XR vector k-it Stratagrene. La
Jolla. CA. USA)1. Clones (200 0001 w~ere plated and anaix sed as
previously described (Tomasetto et al. 1995). Nitrocellulose filters
xwere hN-bridized with the MLNIl37 -'P-labelled cDNA as a probe.
Tw~entv clones w~ere selected. punified and sequenced. One of them
containing 1940 bp corresponded to the complete hHblI cDNA.
Preparation of the hHbl 3' and 5' specific probes
T'he hHblI 3' specific probe w~as released from MLN137 cDNA by
Sau3AI digestion (nt 464-928) and subcloned into pBluescript
Stratag,ene. La Jolla. CA. USA).
T'he hHbl 5' specific probe A-as obtained by EcoRIIHinicll
diaestion of the full-lengrth hHblI cDNA Int 1-327).
RNA preparation and analysis
RNA preparation and anailysis w~ere performed as previously
reported (Tomasetto et al. 1995). After extraction using a cyuani-
dinium isothiocyanate method. total RNAs w~ere fractionated on
1 % agarose gel in the presence of 2.2 m formaldehyde. and trans-
ferred to nvIon membrane (Hvbond N. Amersham Corporation.
Arlington Heights. IL. USA). Northern blots were hvbridized
(5xSSC: 50%l- formnamide: 42'C: 36-48 hI with C'P-labelled
probes. Stringent w~ashings [0.1 xSSC: 0.1%1- sodium dodecylI
sulphate (SDS): 60C] wAere performned tw~ice. Blots w~ere auto-
radiographed at -80WC.
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Figure 1 Schematic representation (A) and pnimary sequence (B) of the human MLN137 protein. (A) The rod diomain of hHbl contains conserved a-helical
structures (lA. lB. 2A and 2B) interrupted by short linker sequences (Li. Ll12 and L2). It is flanked by the N-terminal head and C-terminal tail domains, specific
to hHbl. The relative position of MLN137, 5' hHbl and 3' hHbl cDNA probes along theftull-length hHb1 cDNA are indicated. ORF.open reading frame: UTR.
untranslated region. (B) cDNA and deduced amino acid sequences of MLN137. Nudleotide residues are numbered from 5' to 3' and amino acids in the open
reading frame are designated by the one letter code. The underhlned nucleotide sequence corresponds to the 3' hHbl1 cDNA probe
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FIgure 2 Norn blot analysis of benign and maklnant human breast
tissues using te hHbl 3' probe. Each mne contaried 10 9g of total RNA
From left to right, RNA samples from SK-BR-3 (lae 1), carcinas (lanes
2-6), metasases (anes 7 and 8) and fboaderi (lanes 9-11) are
loaded. A 1.1- transcript is expressed, at various levels, in saine
carinoas (lanes 2,3 and 6), and in one m sample (ane 7). The
3684 probe (Masidawsld et al, 1982) was used as positive iternal control.
AutoracLoxyphy was for 2 days for od 3' hHbl, wher 3684
in was exposed for 16 h- RNA molecular siz are indcated in kb
In situ hybridization
In situ hybridization was performed using a 35S-labelled antisense
RNA probe (5 x 108 c.p.m. gg-'). Formaldehyde-fixed paraffin-
embedded tissue sections (6 im thick) were deparaffinized in
LMR (Labo-Moderne, France), rehydrated and digested with
proteinase K (1 jLg ml-'; 30 min, 37°C). Hybridization was for
18 h, followedby RNase tratment (20 gig ml-'; 30 min; 37°C) and
stringendly washed twice (2 x SSC, 50% formamide; 60°C, 2 h).
Autoradiography was for 2-4 weeks using NTB2 emulsion
(Kodak). After exposure, the slides were developed and counter-
stained using toluidine blue. 35S-labelled sense transcript was
tested in parallel as a negative control.
In vitro translation
In vitro translation of 1 jg of sense MLN137 RNA was performed
using rabbit reticulocyte lysate in the presence of[35S]methionine, as
described by the manufacturer (Promega, Madison, WL USA).
Sixteen ofthe total volume (50gl) ofthe reaction was analysed on
12% sodium dodecyl sulphate polyacrylamide gel electrphoresis
(SDS-PAGE). Dried gels were exposed for 16 h at-8(C.
RESULTS
Nor2th blot analysis of benign and malignant breast
tumours using a hHbl 3' probe
Keratin structure can be subdivided into three parts. There is a
centrl rod occurring in a helical conformation, interrupted by
three short non-helical linkers whose length and sequence are well
conserved in all kerains. This core structure is flanked by anino-
(N-) and carboxy- (C-) terminal non-helical regions, the head and
tail domains, respectively, which are specific to each keratin
(Bloemendal and Pieper, 1989) (Figure IA). MLN137 cDNA
which encodes halfofthe helical domain, the tail domain and the
3' untranslated region (UTR) of hHbl (Figure IA and B),
hybridized with several mRNAs when used as a probe for
Northern blot analysis (data not shown). To avoid these cross-
reactions, we designed a hHbl 3' probe, specific to hHbl,
containing 464 bp located at the 3' end ofthe MLN137 cDNA and
corresponding to the tail domain and part ofthe 3' UTR.
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FIgure 3 Noherm blot analysis of SK43R-3 human brea cancer cel line,
norrral human breast sidn and scalp, using hHbl 3' and 5' probes. 10 ig of
total RNA from SK-BR-3 (lane 1), normnal bre sin (ane 2) and normal
scp (ane 3) were aded. Norhen bot is successively hybed with 3'
hHbl (A), 5' hHb (B) and 3684 (C) probes. (A) 3' hHb probe detected
1.1 kb and 1.9kb mRNA in SK4BR-3 and scap respevely (B) 5' hHb
probe only detected 1.9kb mRNA in scalp. No ta s were detected in
breast sin (A and B). RNA molecular sizes are inicated in kb
The hHbl 3' probe was used to hybridize total RNA extracted
from normal and malignant cells and tissues. Among breast cancer
cell lines, a unique 1.1-kb mRNA was observed in SK-BR-3,
MDA-MB-231 and MCF7, whereas ZR-75-1, BT474, T47D and
BT20 showed no hybridization (Figure 2, lane 1, and data not
shown). In vivo, 7 out of 34 (20%) primary breast carcinomas
expressed the 1.1-kb transcript, to variable intensities (Figure 2,
lanes 2, 3 and 6, and data not shown). Clinical and biochemical
characteristics including the age and menopausal status of the
patients, the presence or absence of lymph node metastases, the
tumour hormonodependency as esimated using oestrogen and
progesterone receptors and the pS2 marker, and the Scarff, Bloom
and Richardson (SBR) tumour grade ofthe seven positive tumours
have been listed in Table 1. No evident relationship could be
drawn between MLN 137 overexpression and any ofthese features
ofthe tumour. One outofthe two metastases studied was alsoposi-
tive (Figure 2, lane 7). Breast fibroadenomas (15 cases studied) as
well as normal adult lung, stomach, colon, liver, kidney and
placenta were negative (Figure 2, lanes 9-11, and data not shown).
On Northern blots, the transcript detected using the hHbl 3'
probe exhibited a size of 1.1 kb. This size was not in accordance
with that of about 2 kb deduced from the full-length hHbl cDNA
(Rogers et al, 1995). However, it fits with that of the MLN137
cDNA (1124bp) cloned from a breast cancer metastasis,
suggesting that breast carcinomas express a 5'-truncated form of
hHbl mRNA.
Cloning of the hHbl 5' probe
To test this hypothesis, we cloned the full-length hHbl cDNA and
designed a hHbl 5' specific probe. Using in situ hybridization, we
hadpreviously observedthatthe hHbl 3'riboprobe hybridized to a
tanscipt present in hair shafts (Regnier et al, 1997). We assumed
that, at this physiological site ofexpression, the transcript detected
should correspond to the complete hHbl mRNA. Thus, we
constructed a scalp cDNA library (see Materials and methods). Its
screening, using the MLN137 probe, led to the identification and
cloning of a full-length hHbl cDNA. A 327-bp fragment of the 5'
end ofthis cDNAcorresponding to the 5' UTRand partofthe head
of hHbl was subcloned to produce a hHbl 5' specific probe
(Figure IA).
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Figure 4 In situ hybndlzatn of normal and malignant breast tissues using
a hHbl 3 rboprobe. Sections of norrnal breast (A) and invasive tumour (B)
were hybridized with antserse [35S]RNA probe specifi for 3' hHb1. (A)
Normal ducts are devoid of signal. (B) The probe detected a tanscrit
sbrngy expressed in the btuoal epitheal cells, whereas the strOal part of
the tumour was totally negative. No sigint lbeling above background
was found when uin sense human 3' hHb1 RNA probe (data not shown).
Bright field (A and B)
Breast carcinomas expressed a hHbl 5'-truncated
mRNA
3' and 5' hHbI probes were used for Nortern blot analysis of
RNA samples extracted from the SK-BR-3 breast cancer cell line.
and from normal breast skin and scalp (Figure 3). Whereas the
hHbl 3'probehybridized totranscripts of 1.1 kband 1.9 kb in SK-
BR-3 and scalp, respectively, the hHbl 5' probe only detected the
1.9-kb mRNA in scalp. As expected. normal breast skin was
devoid of the 1.1-kb and 1.9-kb transcripts. Moreover, using the
hHbl 5' probe. none of the nornal and malignant tissue samples
previously tested with the hHbl 3' probe (Figure 2) gave positive
signals. Together. these findings showed that the 1.1-kb mRNA.
detected in breast carcinomas with the hHbl 3'probe, but not with
the hHbl 5' probe, corresponds to a 5'-truncated form ofthe 1.9-kb
hHbI mRNA normally expressed in hairy skin.
Using a hHbl 3'riboprobe. in situ hybridization showed that the
hHbl 5'-truncated mRNA was specifically expressed by malig-
nant epithelial cells in both primary and secondary tumours
(Figure 4). The stromal compartment of the tumours as well as
normal ducts were negative. These results indicate that the ectopic
expression ofhHb1 5'-truncated mRNA is related to the malignant
status ofmammary epithelial cells.
In vitro translation of the hHbl 5'-truncated (MILN137)
mRNA
Analysis of its sequence showed that MLN137 cDNA encodes an
open reading frame. A classical AATAAA poly(A) addition signal
sequence (Wahle and Keller. 1992) was located 11 bp upstream of
the poly(A) stretch (Figure 1B). Moreover, two potential sites of
initiation of translation were present. giving nrse to putative
proteins corresponding to either the last 202 or 235 amino acids of
the C-terminal part of the hHbl keratin. To determine whether
these sites are functional, we performed in vitro translation of the
MLN137 mRNA. Sense NMLN137 RNA gave rise to a band of
27 kDa. whereas no band was observed using MLN137 antisense
RNA as control (Figure 5). A protein size of 27 kDa is consistent
with a 235-amino acid long protein. Accordingly. the first ATG
codon had the most favourable context for initiation oftranslation
(Kozak, 1996). Thus, the MLN137 mRNA corresponding to the
5'-truncated fonn ofhHbl mRNA is translated in vitro. suggesting
that a N-truncated hHbl keratin could be synthesized in vivo in
some breast carcinomas.
2
Fjtre 5 SDS-PAGE of in vifo tslation of MLN 137 RNA 16l of in vitro
tanslation reaction using sense (Lane 1) and antisense (lane 2) MLN 137
RNA are loaded. A 27-DWa protein is produced using sense RNA (lane 1)
DISCUSSION
From a breast cancer metastasis cDNA library. we have previously
cloned the MLN137 cDNA (Tomasetto et al. 1995) corresponding
to the 3' end of the hHbl hair keratin cDNA (Rogers et al. 1995).
In the present study, using twoprobes specific to the 5' and 3' ends
ofthe hHbl cDNA. we established that breast carcinomas specifi-
cally express a 1.1-kb 5'-truncated form of the hHbl mRNA. In
addition, an in vitro translation study showed that a N-truncated
hHbl protein can be translated. The hHbl 5'-truncated mRNA was
not present in the hair shaft which expresses the wild-type 1.9-kb
hHbl mRNA. With the exception ofhairy skin. all normal tissues
tested so far were devoid of 5'-truncated or wild-type hHbl
mRNA. Moreover, in breast carcinomas, the hHbl 5'-truncated
tanscript is restricted to malignantepithelial cells. showing that its
expression is related to epithelial cell transformation.
The physiological function of keratins is the distribution of
mechanical forces between cells and tissues. and ultimately the
maintenance of epithelial cell integrity. Human soft and hard
keratins are specific to epithelia and hairs and nails respectively.
Intermediate filaments result from the stoichiometric assemblage of
specific type I and type HI keratins (Bloemendal and Pieper, 1989;
Rogers et al, 1997). Abberent forms of soft keratin have been
shown to be responsible for several epidermal genetic diseases.
notably through the formation of dominant negative heterodimers
(Fuchs and Coulombe. 1992; Compton. 1994). In breast carci-
nomas, profiles of soft keratin expression are used as tumour
markers to discrinminate various subtypes oftumours. because they
correlate with different statuses of epithelial cell differentiation
(Trask et al. 1990; Nathrath and Lane, 1994). Finally, aberrant
expression of the soft keratin K13. normally associated with the
terminal differentiation of internal stratified epithelia. has been
reported in mouse skin tumours (Nischt et al. 1988).
Very little is known concerning pathological expression of hard
keratins (Smack et al. 1994). Using in situ hybridization. the hHbl
3'probe revealedthe presence ofatranscript in pilomatricoma indi-
cating that they are tumours of the hair follicle differentiation type
(R6gnier et al. 1997). However, further studies are needed to deter-
mine whether this tanscript corresponds to the wild-type or the 5'-
truncated form ofhHb . In breast carcinomas. this is the first report
ofan ectopic expression ofhard keratin-related gene. About 20% of
invasive breast carcinomas and some of the derived metastases
expressed the hHbl 5'-truncated mRNA. No evident association
between hHbl 5'-truncated mRNA and classical clinical or
biochemical tumourparameters can be drawn. Breast carcinoma is
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an extremely heterogeneous disease (Lonn et al. 1994). and hHbl
5'-truncated mRNA might permit the discrimination between
particularsubtypes ofbreast cancer. Furtherclinical studies are now
required to determine the diagnostic and/or prognostic value ofthe
expression oftruncated hHb1.
S'-truncated forms of mRNA could result from gene alterations
occurring during cell transformation, such as partial gene deletion
or gene mutation(s) leading to altered splicing. Another possibility
is that the hHbl '-truncated mRNA results from gene transloca-
tion. as previously reported forthe PML to RAR-a translocation in
myeloid and lymphoid leukaemias for example (Sawyers. 1997).
In this context we note that the hHbl gene maps to the 12q1 l-q13
band of the human genome (Rogers et al. 1995). a region already
known to be involved in chromosome translocation in a wide
variety ofsolid tumours. notably breast carcinomas (Van de Ven et
al, 1995). Thus. it is tempting to speculate that gene translocation
leading to aberrant genes containing the 3' coding region ofhHbl
fused to the regulatory sequences ofanother gene could be respon-
sible for the expression of the truncated hHbl. In this case, it will
be of interest to determine the nature of this gene specifically up-
regulated in breast carcinomas. Sequencing ofupstream regulatory
regions ofthe corresponding genomic DNA extracted from breast
carcinomas and FISH experiments performed on breast cancer
cells will enable us to test this attractive hypothesis.
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